Connect with us

Health

Johnson & Johnson stop production of Covid-19 vaccine; what it may signal

Published

on

By Dana Malcolm

Staff Writer

 

February 16, 2022 – Johnson & Johnson has officially halted production at all of its Covid-19 vaccine producing facilities; this comes after last week’s announcement that some production would be stopped for the pharmaceutical company to shift focus to a new vaccine, unrelated to Covid-19.

The move comes as vaccination drives slow in higher income countries especially those in Europe and they begin to cancel Covid-19 restrictions.

Johnson & Johnson said, “We strive to improve human health and have worked tirelessly to … build a global manufacturing network across four continents to produce our COVID-19 vaccine. Our manufacturing sites produce multiple products as we have an obligation to supply life changing medicines to patients around the world and bring forward our innovative pipeline of new medicines and vaccines. We manage our production planning accordingly and are currently supplying from our extensive global network based on the demand for our vaccine and the needs of our patients and customers.”

The pharmaceutical company announced on February 8 that the plant would cease COVID19 operations temporarily to work on another vaccine for a different virus The New York Times reports.

The move prompted immediate fears from organizations like COVAX  and the African Union which depends on the Johnson & Johnson vaccine to meet their quotas and distribute the vaccines to poorer countries worldwide.

Despite the controversy surrounding the vaccine and its effects in relation to blood clotting Johnson & Johnson has been one of the most distributed brands in the world.

The company has said that they supply based on the needs of patients and customers but only 54 per cent of the world has been fully vaccinated against COVID-19 so far. Notable is the staggering unevenness of the vaccination: only 11 per cent of the population has received one dose of a vaccine in low income countries.  Conversely, high income countries have successfully vaccinated over 78 per cent of their populations.

Johnson & Johnson is currently in use in 82 different countries worldwide.

This begs the question of why Johnson & Johnson is stopping production when there are so many persons in lower income countries especially still depending on its vaccine

The NY Times also reports that neither COVAX or The African Union were informed of the decision by Johnson & Johnson beforehand.

The African Union said, “This is not the time to be switching production lines of anything, when the lives of people across the developing world hang in the balance.”

COVAX expressed similar sentiments. They said that Johnson & Johnson had already let them down in 2021 and they couldn’t of the word to be let down in 2022.

In response J&J said “We are focused on ensuring our vaccine is available where people are in need, and we continue to fulfill our contractual obligations in relation to the COVAX Facility and the African Union, we currently have millions of doses of our COVID-19 vaccine in inventory.”

Johnson & Johnson struggled with vaccines expiring before they were able to be used early in production. The FDA extended the expiry dates in July last year from the initial four and a half months.

The vaccines currently have a shelf life of six months.

Health

Dengue cases rising in Region 

Published

on

Dana Malcolm 
Staff Writer 

As of March 26, 2024, over 3.5 million cases of dengue and more than 1,000 deaths have been reported in the region, now, both the US Centres for Disease Control (CDC) and the Pan-American Health Organization (PAHO), are ringing alarm bells about the outbreak as cases swell to record highs.

PAHO on March 28 called for collective action in the region to fight back the growing wave of infections.

“This is cause for concern, as it represents three times more cases than those reported for the same period in 2023, a record year with more than 4.5 million cases reported in the region,” Jarbas Barbosa, PAHO Director said during a press briefing.

For now cases are concentrated in three main countries: Brazil, Paraguay and Argentina which account for nearly all of them, around 92 percent, but infections are on the rise regionally.

According to Barbosa, Caribbean countries must still be vigilant as data is beginning to show increases in areas like Barbados. That is paired with concerns from PAHO that some countries may not be equipped to handle the surge.

Nearly $500,000 was allocated in the 2023 2024 budget to the environmental health department under The Turks and Caicos Ministry of Health and Human Services to help with dengue which had been listed as a public nuisance.

Last year in the Turks and Caicos Islands, only a few rounds of fogging were completed. According to data from the Appropriations Committee around 10% of communities were fogged on schedule. Explaining the low number, representatives of the Environmental Health Department (EHD) maintained that fogging was not the primary defense against mosquito breeding locally.

”Fogging should actually be a last resort, there are preventative measures such as the treatment of swamps, and inspection of residential areas and communities for breeding sites.”

Representatives admitted though that they were still hampered by a lack of resources.

The country declared an outbreak in late 2024. Now there is an ongoing public education campaign to make residents aware of what they need to do to keep their homes safe and free from mosquitoes in addition

The Turks and Caicos Islands EHD also says they have been provided with money to help with garbage disposal in their battle against the vector borne disease.

The Ministry has also contracted entomologists to research what kind of mosquitoes live in the country and how to tackle them.

Continue Reading

Health

31 Turks & Caicos Medical Professionals, Trained in Trauma care

Published

on

Dana Malcolm 
Staff Writer 

In a first for the Turks and Caicos and one that some would describe as particularly important, over three dozen healthcare professionals were upskilled in emergency trauma care via Advanced Trauma Life Support (ATLS) certification.

Trauma Care in emergency medicine usually refers to treating patients who are critically ill or have severe injuries and need to be quickly stabilized like gunshot wounds, damaged limbs, crush injuries, and stab wounds.

In 1976 following a plane crash involving a surgeon and his children who experienced substandard trauma care, the first ATLS course was created. It attempts to provide basic training for medical professionals when dealing with acute trauma cases where there is little staff on hand. In fact ATLS is supposed to work with as little as a single doctor and nurse team working together to stop the most critical injuries first, ensuring a better chance of survival.

This is particularly useful for the Turks and Caicos with its small hospitals and limited staff. Health officials admitted this, highlighting what they describe as ‘the pressing need for such training, particularly due to physician shortage, isolated communities in family islands and other barriers to accessing this critical training.’

Recognizing the need, the Hamilton Education Foundation jumped into action, and in collaboration with Massachusetts General Hospital and the American College of Surgeons conducted a Hybrid Advanced Trauma Life Support (ATLS) Demo for 31 doctors in the Turks and Caicos Islands on May 22nd and 23rd, 2024.

Led by Professor Susan Briggs,the foundation describes the course as historic in that it’s the first-ever done outside the United States and says it is;“Crucial for enhancing the quality of healthcare delivery and saving lives in the face of increasing intentional and unintentional injuries.”

With the rise in gunshot injuries in the country, seen through police data since 2020 many residents might be inclined to agree.

While admitting it was difficult to measure if ATLS reduced mortality, a 2016 article published in the National Library of Medicine describes the courses as “very useful from an educational point of view. It significantly increased knowledge, and improved practical skills and the critical decision making process in managing multiple trauma patients”

Rufus Ewing, Former Premier and Executive Chairman of the Hamilton Education Foundation, said, “This initiative aligns with our mission to enhance medical education and improve access to quality healthcare services in the Turks and Caicos Islands.”

The training received broad brush support from the Ministry of Health, TCI Hospital and private sector.

Continue Reading

Caribbean News

Dengue surges in Argentina; Repellent shortage reported

Published

on

Rashaed Esson

Staff Writer 

 

#Argentina, April 15, 2024 – Argentina is currently facing a shortage in mosquito repellents, a severely unfortunate development for the nation as it is now fighting a surge in dengue cases, in-line with PAHO predictions that the region will face its worst dengue season on record.

The mosquito repellent shortage was reportedly noticed in March 2024 and Argentina, according to the Ministry of Health, recorded over 163,000 cases with deaths in all age groups, more common for those over 80 years old.

The situation is widespread across Argentina as indicated by supermarkets putting on display “no repellent” signs.

Places where repellents are still available,  online spaces especially, are selling them at high prices.

As to the reason behind the shortage, BBC reports that it was told by one of the production companies (for repellents), that a forecast error was at fault and that manufacturing took months.  Additionally, mirroring this,  Mario Russo reports a supply and demand problem.

The Government is making efforts to have this sorted as soon as possible, but Argentinians, reports say, are not so hopeful as hundreds of thousands have already been infected.

Preventative measures such as repellents are crucial for Argeniniand who reply heavily on them, as they await the dengue vaccine which is already developed, but still In its early stages of distribution.

Continue Reading

FIND US ON FACEBOOK

TRENDING